Detalhe da pesquisa
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652353
2.
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 586(7830): 594-599, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998157
3.
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine Immunogenicity.
J Immunol
; 210(6): 764-773, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723033
4.
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Clin Infect Dis
; 75(3): 390-398, 2022 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940806
5.
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 590(7844): E17, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469214
6.
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
Clin Infect Dis
; 73(7): e1489-e1497, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716500
7.
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
J Infect Dis
; 220(1): 105-115, 2019 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778554
8.
A Phase 3, Single-Arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
Pediatr Infect Dis J
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502894
9.
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38535409
10.
Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis.
J Infect Dis
; 205(11): 1688-96, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22474033
11.
A Longitudinal Study of Group A Streptococcal Colonization and Pharyngitis in US Children.
Pediatr Infect Dis J
; 42(12): 1045-1050, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768176
12.
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Vaccine
; 40(33): 4872-4880, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810060
13.
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.
Hum Vaccin Immunother
; 17(7): 2249-2256, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545022
14.
Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease.
Microorganisms
; 9(1)2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467609
15.
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.
Vaccine
; 39(38): 5428-5435, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34315611
16.
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.
Vaccine
; 39(51): 7494-7502, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839993
17.
A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age.
Hum Vaccin Immunother
; 17(8): 2691-2699, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661716
18.
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Lancet Infect Dis
; 21(2): 263-274, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891191
19.
Immunofluorescence Microscopy for the Detection of Surface Antigens in Methicillin Resistant Staphylococcus aureus (MRSA).
Methods Mol Biol
; 2069: 47-58, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31523764
20.
Vaccination against Nosocomial Infections in Elderly Adults.
Interdiscip Top Gerontol Geriatr
; 43: 193-217, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305976